Background {#s1}
==========

Protein kinases are a large family of homologous proteins with more than 500 members in the human proteome \[[@R01]\]. Kinasemediated protein phosphorylation is a crucial component of the signal transduction pathways which plays a central role in diverse biological processes such as cell growth, metabolism, differentiation, and apoptosis \[[@R02]\]. A number of diseases, including cancer, diabetes, inflammation, immune and neurodegenerative disorders are linked to perturbation of protein kinase--mediated cell signaling pathways \[[@R03]\]. Since all members of the kinase families utilize ATP, kinase inhibitors are designed to bind with the ATP to prevent substrate phosphorylation \[[@R01]\].

Over 20 small-molecule protein kinase inhibitors have been currently approved and more than 150 kinase inhibitors are undergoing clinical trials \[[@R04]\]. Yet, issues such as target specificity, \[[@R05],[@R06], [@R07],[@R08]\] resistance development \[[@R09],[@R10]\] hinge region binding and activation state dependence of kinase inhibitors need to be addressed \[[@R02],[@R03],[@R04]\].

The three-dimensional structures of proteins with bound ligand are available in the Protein Data Bank \[[@R11]\] along with their experimental binding affinity information. Binding affinity data such as Ki, Kd, IC50 etc. obtained from experimental studies are also available in databases such as BindingDB \[[@R12]\], Binding MOAD \[[@R13]\], PDBbind \[[@R14]\] etc. Availability of valuable resources regarding kinase inhibitors made computational biologists to develop statistical models to accurately predict the binding affinity of complexes.

Structure-based virtual screening methods use docking programs to explore the possible binding modes of a ligand within the target binding site, and scoring functions to estimate the affinity of the ligand for the binding site \[[@R15],[@R16]\]. While docking methods at present are in general successful in predicting the correct binding conformations of ligand molecules, they do not perform well in correctly predicting the binding affinity for the predicted ligand conformations \[[@R02]\]. Hence, it is essential to predict the binding affinity of a given ligand to its target known as the 'scoring problem' \[[@R17]\].

As a pioneering work, Bohm \[[@R18]\] (1994) developed a simple empirical function (LUDI) to estimate the binding constant for a protein-ligand complex of known structure. This empirical scoring function takes into account hydrogen bonds, ionic interactions, the lipophilic protein-ligand contact surface and the number of rotatable bonds in the ligand. Head et al. (1996) in their VALIDATE approach used electrostatic and steric interaction energies, octanol-water partition coefficient, polar and nonpolar contact surfaces, and a term to describe intramolecular flexibility \[[@R19]\]. Following the approach of Bohm, \[[@R18]\] Eldridge et al. \[[@R20]\] (1997) included intramolecular flexibility in ChemScore and Wang et al. \[[@R21]\] (1998) classified hydrogen bonds and included the occurrence of interstitial water molecules in SCORE. Based on the statistical analysis of experimentally observed distributions and frequencies of distance-dependent protein-ligand atom pair interactions, the potential of mean force (PMF) was obtained which has been used for affinity predictions of large datasets \[[@R22]\]. Based on a larger set of 200 protein--ligand complexes, Wang et al. (2002) developed X-Score \[[@R17]\], consisting of four energy terms including van der Waals interactions, hydrogen bonds, hydrophobic effects and effective rotatable bonds. Docking programs such as FlexX \[[@R23]\] and Surflex \[[@R24]\] use empirical scoring functions by including different empirical energy terms. A large-scale validation of a quantum mechanics based scoring function to predict the binding affinity and binding mode of a diverse set of protein-ligand complexes containing different protein families including aspartic proteases, serine proteases, sugar binding proteins, amino acid binding proteins, and protein kinases was done by Raha and Merz (2004) \[[@R25]\]. LigScore functions \[[@R26]\] have made use of three distinct terms, the van der Waals interaction, the polar attraction between the ligand and protein, and the desolvation penalty attributed to the binding of the polar ligand atoms to the protein to predict the experimental pKi values of a diverse set of 118 protein--ligand complexes that span more than seven protein families. CLiBE, a database of computed ligand binding energy (based on molecular mechanics force field) for ligand-receptor three dimensional structures have been developed and a linear correlation between the computed ligand-receptor interaction energy and experimental binding affinity (Kcal/mol) has been observed \[[@R27]\]. A Program for Energetic Analysis of Receptor-Ligand System (PEARLS) has been developed to compute free energy of protein-ligand complexes \[[@R28]\].

While the above methods use the known three dimensional structures to predict binding affinities, the Quantitative Structure-Activity Relationship (QSAR) methods serve as an alternative way of binding affinity predictions in the absence of 3D structure of target proteins or their complexes with ligands. These methods make use of physicochemical and structural properties (descriptors) of ligands to relate their biological activity using regression methods. Combined QSAR approaches in binding affinity predictions have been recently reported \[[@R29],[@R30]\].

In the present work, we have correlated the experimental IC50 values (in their logarithmic form) of 25 different kinase-inhibitor complexes with their protein- interaction energy and partition coefficient (logP) values for multiple regression analysis, which shows a good correlation with the experimental IC50 values. This shows that the protein-ligand interaction energies and logP values form the major factors that determine the ligand binding affinity of proteins. By incorporating these energetic as well as solvent terms, docking methodologies can be highly successful in predicting the binding affinity for the generated poses of their correct ligand binding modes.

Methodology {#s2}
===========

Information resources {#s2a}
---------------------

Twenty five different protein kinase-inhibitor complexes solved by x-ray crystallography method were obtained from Protein Data Bank \[[@R11]\]. The complexes in the dataset have resolution less than 2.5 Å with known IC50 values were treated as training set. The number of non-hydrogen atoms of the ligands and energetic profile comprising of i) total ligand-receptor interaction energy, ii) van der Waals energy, iii) electrostatic energy, iv) hydrogen bond energy, v) solvation free energy, vi) conformational entropy and vii) ligand-water-receptor binding energy were obtained from the PEARLS server for each of the kinase-inhibitor complexes. The PEARLS server uses the AMBER force field \[[@R31]\] for computing the above energetic contributions \[[@R28]\]. LogP (octanol/water partition coefficient) values of the ligands were calculated from the Molinspiration server \[[@R32]\] by providing SMILES code of the ligand as input.

Training set construction and validation {#s2b}
----------------------------------------

Multiple regression analysis was carried out to establish a relationship between the above-mentioned descriptors and experimental log (IC50). A back-check test was carried out for predicting the binding affinity by re-substituting the values in the regression equation obtained. For the jack-knife test, coefficients of multiple regressions were determined using (n-1) data (omitting one protein-ligand complex at a time) and then predicting binding affinity of the omitted protein-ligand complex.

Test set information {#s2c}
--------------------

The regression equation obtained from the training set was tested on i) a set of 93 kinase-inhibitor complexes with IC50 values, and ii) a set of 9 approved kinase inhibitors \[[@R02]\].

To further assess the predominant role of the chosen descriptors in binding affinity predictions, the experimental log (IC50) values were regressed with the same set of nine descriptors in five independent protein-kinase families comprising 17 cyclic AMPdependent kinase-inhibitors, 12 casein kinase-inhibitors, 15 hepatocyte growth factor receptor kinase-inhibitors, 12 cyclindependent kinase-inhibitors and 16 mitogen-activated kinaseinhibitors. For each of the five kinase families, five different regression equations were obtained which were then validated by back-check analysis. The dataset information of all the kinaseinhibitor complexes used in the present study, including PDB ID, protein name, ligand ID, x-ray resolution (Å), experimental IC50 values (nM) with their logarithmic form, and descriptor values are provided in the Appendix.

Discussion {#s3}
==========

The following multiple regression equation (1) between log (IC50) values and nine energetic descriptors and log P with a correlation coefficient, r = 0.93 was obtained for the training set of 25 kinaseinhibitor complexes.

log (IC50) = -- 0.07 NHA + 44.71 IE -- 44.61 vdW -- 44.51 Elect -- 44.47 H-bonds -- 45.45 Solv -- 43.19 entropy -- 42.82 H-bonds (water-mediated) + 0.18 LogP + 3.58 (1)

where NHA denotes the number of non-hydrogen atoms of the ligand, IE, the total Ligand-receptor interaction energy (Kcal/mol), vdW, the van der Waals energy (Kcal/mol), Elect, the electrostatic Energy (Kcal/mol), H-bonds, the hydrogen bond energy (Kcal/mol), Solv, the solvation free energy (Kcal/mol), entropy, the conformational entropy (Kcal/mol), H-bonds (water-mediated), the ligand-water-receptor binding energy (Kcal/mol) and logP, (the octanol-water) Partition coefficient.

The experimentally observed and predicted IC50 values for 25 kinase-inhibitor complexes in back-check and jack-knife predictions are provided in [Table 1](#T1){ref-type="table"}. The average deviation of the predicted log (IC50) values from the experimental log (IC50) values was 0.41 for back-check and 0.63 for jack-knife predictions respectively. The relationship between the experimental log (IC50) values with back-check and jack-knife predictions are provided as scatter plots in [Figure 1a and 1b](#F1){ref-type="fig"}

a) Test set of diverse protein kinases (Test set I) {#s3a}
---------------------------------------------------

The regression equation (1) obtained was tested on 93 kinaseinhibitor complexes (results are provided as [Table 7](#T7){ref-type="table"} in the Supporting Information file) and the relationship between the experimental and predicted log (IC50) values is presented as a scatter plot ([Figure 2](#F2){ref-type="fig"}). An average deviation of 0.92 from the original log (IC50) values was observed for the 93 kinase-inhibitor complexes. The difference between the experimental and calculated log (IC50) values was found to be less than ±1 log unit for 64 out of 93 kinase-inhibitor complexes.

b) Approved kinase inhibitors as test set (Test set II) {#s3b}
-------------------------------------------------------

To further test the predictability of our regression equation (1), we have tested it for nine approved kinase inhibitors2. The experimental values of those inhibitors were found to have minimum and maximum range of values. Hence, the mean value between the logarithm of minimum and maximum values were calculated and compared with the predicted values. The predicted values were almost closer (the deviation was less than 1) to the experimental log (IC50) values in 7 out of 9 kinaseinhibitor complexes ([Table 2](#T2){ref-type="table"}).

c) Kinase classes {#s3c}
-----------------

In order to further validate the use of the same set of descriptors in predicting binding affinity, the experimental IC50 values of five kinase families were regressed. The regression equation obtained for individual kinase families and the result of back-check predictions are discussed as follows:

i) Cyclic AMP-dependent protein kinase-inhibitor complexes {#s3d}
----------------------------------------------------------

For a data-set of 17 cyclic AMP-dependent protein kinaseinhibitor complexes, a correlation value of 0.95 was obtained using the regression equation (2)

log (IC50) = -0.06 NHA -- 76.09 IE + 76.08 vdW + 75.98 Elect + 76.26 H-bonds + 76.62 Solv + 75.21 entropy + 77.07 H-bonds (water-mediated) -- 0.13 LogP + 5.21 (2)

Using the regression equation (Eq. 2), log (IC50) values for 17 cyclic AMP-dependent protein kinase-inhibitor complexes were predicted. The experimental as well as predicted log (IC50) values are presented ([Table 3](#T3){ref-type="table"}) and plotted ([Figure 3a](#F3){ref-type="fig"}). The average deviation for the back-check test was 0.28 from the experimental values.

ii) Casein kinase-inhibitor complexes {#s3e}
-------------------------------------

12 casein kinase-inhibitor complexes were taken for the multiple regression analysis which has shown a good correlation of r = 0.97 for the regression equation (3)

log (IC50) = 0.01 NHA -- 1.40 IE + 1.45 vdW + 1.39 Elect + 1.36 Hbonds + 1.43 Solv + 1.35 entropy + 1.69 H-bonds (watermediated) + 0.01 LogP + 0.47 (3)

The set of 12 casein kinase-inhibitor complexes with their experimental and predicted values has been provided ([Table 4](#T4){ref-type="table"}). The scatter plot shows the relationship between the experimental and predicted IC50 values ([Figure 3b](#F3){ref-type="fig"}), the average deviation being 0.02 for back-check predictions.

iii) Hepatocyte growth factor receptor kinase-inhibitor complexes {#s3f}
-----------------------------------------------------------------

A set of 15 hepatocyte growth factor receptor kinase-inhibitors has shown a correlation coefficient value of 0.90 when subjected to regression with multiple descriptors, the equation (4) being

log (IC50) = 0.05 NHA -- 232.16 IE + 231.87 vdW + 231.02 Elect + 232.03 H-bonds + 232.68 Solv + 224.75 entropy +236.13 H-bonds (water-mediated) -- 0.27 LogP + 0.24 (4)

The experimental and predicted log (IC50) values are provided in [Table 5](#T5){ref-type="table"}. The correlation between experimental and calculated values for the 15 hepatocyte growth factor receptor kinaseinhibitors is shown in [Figure 3c](#F3){ref-type="fig"}. An average deviation of 0.31 was observed.

iv) Cyclin-dependent kinase-inhibitor complexes {#s3g}
-----------------------------------------------

A very good correlation of r = 0.94 was obtained for 12 cyclindependent kinase-inhibitor dataset using the regression equation (5)

log (IC50) = -- 0.35 NHA + 94.15 IE -- 94.18 vdW -- 96.24 Elect -- 92.97 H-bonds -- 92.06 Solv --96.77 entropy -- 95.47 H-bonds (water-mediated) + 1.94 LogP + 6.27 (5)

The predicted results of 12 cyclin-dependent kinase-inhibitor complexes are tabulated ([Table 6](#T6){ref-type="table"}). The average deviation value from the experimental value was found to be 0.49. The results are plotted ([Figure 3d](#F3){ref-type="fig"}).

v) Mitogen-activated protein kinase-inhibitor complexes {#s3h}
-------------------------------------------------------

The multiple regression analysis of 16 mitogen-activated protein kinase-inhibitors gave a correlation of r = 0.94 using the regression equation (6)

log (IC50) = -- 0.13 NHA + 16.62 IE -- 16.05 vdW -- 17.09 Elect -- 16.66 H-bonds -- 16.62 Solv -- 13.78 entropy -- 18.19 H-bonds (water-mediated) + 0.40 LogP + 8.27 (6)

The observed and computed values for a dataset of 16 mitogenactivated protein kinase-inhibitors are presented ([Table 7](#T7){ref-type="table"}) showing an average deviation value of 0.29. The predicted IC50 values were plotted against the experimental values ([Figure 3e](#F3){ref-type="fig"}).

In QSAR studies, usually a large number of physicochemical and structural properties (descriptors) of chemical compounds are calculated and the best combinations of descriptors that correlate maximally with the biological activity are chosen. QSAR models have been developed for predicting kinase selectivity profiles to provide understanding of structure selectivity relationships for kinase inhibitor design \[[@R33],[@R34], [@R35]\]. The development of widely accepted 'universal' set of descriptors applicable for diverse datasets has also been a focus of QSAR-based analysis \[[@R36],[@R37], [@R38]\]. In the present work, a uniform set of descriptors have been used across different kinase-inhibitor complexes for binding affinity prediction.

Han et al. (2006) suggested that the calculated interaction energies highly depend on van der Waals contacts, electrostatic interactions, hydrogen bonds, metal-receptor binding, and solvation \[[@R28]\], which agrees with the observations of our present analysis. These observations are reflected in the interaction energy contributions of our present analysis. The protein-ligand interaction energies obtained using PEARLS server has been used in other studies on inhibitor discovery such as HIV-1 protease \[[@R39]\] and ribonuclease A inhibitors \[[@R40]\] to predict the binding affinity values using regression analysis. Log P, remains the main deterministic factor for the ligand's affinity for the protein active site with reference to the surrounding solvent environment \[[@R41]\].

In the present study, we have used the various energetic components as independent variables along with logP values, to predict the experimental binding affinity. This set of descriptors developed from a small set of 25 kinase-inhibitor complexes were able to predict IC50 values for 93 test set complexes spanning 4 orders of magnitude of IC50 values. The same set of descriptors was also found to be suitable for family specific regression models as well.

As docking methods improve to reproduce conformations observed through x-ray crystallographic and NMR determined structures, it will be possible to use our present approach to predict the IC50 values for various protein targets, more significantly for specific protein families. Alternatively, if IC50 values for kinase-inhibitor complexes are known, the method can also be used to predict the pose of a given ligand as well.

Conclusion: {#s4}
===========

Despite intensive research over more than two decades, accurate prediction of the binding affinities of large set of diverse protein ligand complexes remains one of the most important open problems in computational molecular biology \[[@R42]\]. The issues currently being addressed are the scoring of modelled protein conformations, and including the binding free energy due to presence of water molecules \[[@R43]\]. In the present work, we have addressed these issues by using energetic and solvent descriptors to predict the binding affinity of kinase-inhibitor complexes using multiple regression analysis. A high correlation value of 0.9 between the predicted and experimental binding affinity was obtained for a test set of kinase-inhibitor complexes. The method was validated by predicting a test of 93 kinase-inhibitor complexes covering five kinase families which has shown a good predictive ability. Our methodology can provide valuable insights for the prediction accuracy of molecular docking strategies. Further studies will be required to validate the general applicability of these set of descriptors to predict the binding affinity for a diverse set of enzyme-inhibitor complexes.

SS thanks the University Grants Commission, New Delhi for the award of Emeritus Fellowship (Grant No: F.6-6/ 2014-15/ EMERITUS-2014-15-GEN-4545/ (SA-II)).

**Edited by P Kangueane**

**Citation:**Usha & Selvaraj, Bioinformation 12(3): 172-181 (2016)

###### Experimentally observed and predicted IC50 values for 25 kinase-inhibitor complexes.

  PDB_ID                                                                                            Ligand_ID   Experimental IC50(nM)   Experimental Log (IC50(nM))   Predicted log(IC50 (nM))   
  ------------------------------------------------------------------------------------------------- ----------- ----------------------- ----------------------------- -------------------------- -----------------
                                                                                                                                                                      Back-check                 Jack-knife test
  2I6A                                                                                              5I5         22.8                    1.36                          1.33 (0.03)                1.30(0.06)
  2OO8                                                                                              RAJ         1                       0                             0.26 (-0.26)               0.48 (-0.48)
  4AT3                                                                                              LTI         4                       0.6                           0.28 (0.32)                0.13 (0.47)
  3SXF                                                                                              BK5         5                       0.7                           0.69 (0.01)                0.69 (0.01)
  2C1A                                                                                              I5S         170                     2.23                          1.43 (0.80)                1.96 (0.27)
  3MB6                                                                                              01I         100                     2                             1.71 (0.29)                1.54 (0.46)
  1Y6B                                                                                              AAX         38                      1.58                          0.85 (0.73)                1.90 (-0.32)
  2A4L                                                                                              RRC         400                     2.6                           2.82 (-0.22)               2.90 (-0.30)
  2YAK                                                                                              OSV         2                       0.3                           0.24 (0.07)                0.17 (0.13)
  4GK2                                                                                              L66         40                      1.6                           1.55 (0.05)                1.53 (0.07)
  3POZ                                                                                              03P         23                      1.36                          1.65 (-0.28)               1.91 (-0.55)
  4F64                                                                                              0S8         63                      1.8                           2.00 (-0.20)               2.15 (-0.35)
  3BZ3                                                                                              YAM         1.5                     0.18                          0.27 (-0.09)               0.33 (-0.15)
  1Q3D                                                                                              STU         15                      1.18                          1.28 (-0.11)               1.34 (-0.16)
  3C1X                                                                                              CKK         45                      1.65                          1.01 (0.64)                0.68 (0.97)
  3D94                                                                                              D94         19                      1.28                          0.96 (0.32)                0.77 (0.51)
  4BKZ                                                                                              1WS         27                      1.43                          1.87 (-0.43)               2.20 (-0.77)
  3HRB                                                                                              I39         21                      1.32                          1.80 (-0.48)               1.93 (-0.61)
  4BFV                                                                                              ZVV         140                     2.15                          1.45 (0.70)                0.54 (1.61)
  3LJ3                                                                                              WYE         43                      1.63                          2.12 (-0.49)               2.74 (-1.10)
  2VGO                                                                                              AD5         500                     2.7                           1.93 (0.77)                1.39 (1.31)
  4HDC                                                                                              13Y         1.2                     0.08                          0.37 (-0.29)               0.77 (-0.69)
  1RW8                                                                                              580         1320                    3.12                          2.96 (0.16)                2.84 (0.28)
  3KRR                                                                                              DQX         0.48                    -0.32                         -0.26 (-0.06)              -0.16 (-0.16)
  3MVH                                                                                              WFE         0.5                     -0.3                          0.05 (-0.35)               0.19 (-0.49)
                                                                                                                                        Average deviation             0.41                       0.63
                                                                                                                                                                                                 
  Note: The deviation between the predicted and experimental IC50 values is given in parenthesis.                                                                                                

###### Prediction of experimental log (IC50) values in approved kinase inhibitors.

  S.NO.                                                                                                                  PDB ID   Protein name                                           Ligand ID   Ligand name     Experimental log (IC50 (nM))   Predicted log (IC50(nM))
  ---------------------------------------------------------------------------------------------------------------------- -------- ------------------------------------------------------ ----------- --------------- ------------------------------ --------------------------
  1                                                                                                                      1M17     Epidermal growth factor receptor                       AQ4         Erlotinib       \- 0.70 -- 3.16 (1.23)         0.87
  2                                                                                                                      1IEP     Proto-oncogene tyrosine-protein kinase abl             STI         Imatinib        0.04 -- 3.93 (1.99)            1.79
  3                                                                                                                      2ITY     Epidermal growth factor receptor                       IRE         Gefitinib       0.00 -- 3.44 (1.72)            1.46
  4                                                                                                                      2J2I     Proto-oncogene serine/threonine-protein kinase pim-1   LY4         Ruboxistaurin   2.3                            1.61
  5                                                                                                                      2GQG     Proto-oncogene tyrosine-protein kinase abl1            1N1         Dasatinib       \- 0.70 -- 2.85 (1.07)         -0.97
  6                                                                                                                      2JAV     Serine/threonine-protein kinase nek2                   5Z5         Sunitinib       3.9                            1.02
  7                                                                                                                      1UWH     B-raf proto-oncogene serine/threonine-protein kinase   BAX         Sorafenib       1.04 -- 3.86 (2.45)            1.12
  8                                                                                                                      1XKK     Epidermal growth factor receptor                       FMM         Lapatinib       0.46 -- 2.64 (1.55)            1.88
  9                                                                                                                      2F2U     Rho-associated protein kinase 2                        M77         Fasudil         2.26 -- 4.07 (3.16)            2.45
                                                                                                                                                                                                                                                    
  Note: The mean value between the logarithm of minimum and maximum experimental IC50 values are given in parenthesis.                                                                                                                              

###### Experimentally observed and predicted IC50 values for 17 cyclic AMP-dependent protein kinase-inhibitor complexes.

  PDB_ID                                                                                            LIG_ID   Experimental IC50 (nM)   Experimental log ( IC50 (nM))   Back-check Prediction
  ------------------------------------------------------------------------------------------------- -------- ------------------------ ------------------------------- -----------------------
  1STC                                                                                              STU      51                       1.71                            1.45 (0.26)
  1SVE                                                                                              I01      5                        0.7                             0.99 (-0.29)
  1XH4                                                                                              R69      30                       1.48                            1.58 (-0.10)
  1YDS                                                                                              IQS      5300                     3.72                            3.13 (0.59)
  2C1A                                                                                              I5S      170                      2.23                            2.23 (0.00)
  2F7X                                                                                              4EA      38                       1.58                            1.64 (-0.06)
  2GNI                                                                                              M77      7605                     3.88                            3.59 (0.29)
  2JDS                                                                                              L20      27                       1.43                            1.45 (-0.01)
  2OH0                                                                                              2PY      18                       1.26                            1.21 (0.04)
  2OJF                                                                                              4PY      110                      2.04                            2.15 (-0.11)
  2UW6                                                                                              GVO      280                      2.45                            3.07 (-0.62)
  2UZT                                                                                              SS3      14                       1.15                            1.11 (0.04)
  3L9L                                                                                              L9L      167                      2.22                            1.78 (0.45)
  3MVJ                                                                                              XFE      3200                     3.51                            3.77 (-0.27)
  3OW3                                                                                              SMY      742                      2.87                            2.88 (-0.01)
  3ZO2                                                                                              15I      80                       1.9                             2.10 (-0.19)
  4C35                                                                                              NU3      560                      2.75                            2.76 (-0.01)
                                                                                                                                      Average deviation               0.28
                                                                                                                                                                      
  Note: The deviation between the predicted and experimental IC50 values is given in parenthesis.                                                                     

###### Experimentally observed and predicted IC50 values for 12 casein kinase-inhibitor complexes.

  PDB_ID                                                                                            LIG_ID   Experimental IC50 (nM)   Experimental log ( IC50 (nM))   Back-check Prediction
  ------------------------------------------------------------------------------------------------- -------- ------------------------ ------------------------------- -----------------------
  2QC6                                                                                              G12      100                      0.27                            0.24 (0.03)
  2ZJW                                                                                              REF      40                       0.38                            0.37 (0.01)
  3AMY                                                                                              AGI      800                      0.36                            0.38 (-0.02)
  3BQC                                                                                              EMO      2000                     0.18                            0.20 (-0.03)
  3MB6                                                                                              01I      100                      0.24                            0.25 (0.00)
  3PE1                                                                                              3NG      1                        0.2                             0.21 (-0.01)
  3PWD                                                                                              CZ0      220                      0.34                            0.31 (0.03)
  3R0T                                                                                              FU9      0.91                     0.24                            0.24 (0.01)
  3RPS                                                                                              4B0      320                      0.36                            0.37 (-0.01)
  3U4U                                                                                              LNH      3100                     0.34                            0.34 (0.01)
  4ANM                                                                                              WUL      28                       0.23                            0.22 (0.01)
  4DGM                                                                                              AGI      1200                     0.22                            0.23 (-0.02)
                                                                                                                                      Average deviation               0.02
                                                                                                                                                                      
  Note: The deviation between the predicted and experimental IC50 values is given in parenthesis.                                                                     

###### Experimentally observed and predicted IC50 values for 15 hepatocyte growth factor receptor kinase-inhibitor complexes.

  PDB_ID   LIG_ID   Experimental IC50 (nM)   Experimental log ( IC50 (nM))   Back-check Prediction
  -------- -------- ------------------------ ------------------------------- -----------------------
  2WD1     ZZY      82                       1.91                            1.56 (0.36)
  2WKM     PFY      9                        0.95                            1.26 (-0.30)
  3C1X     CKK      45                       1.65                            1.56 (0.09)
  3CCN     LKG      120                      2.08                            1.69 (0.39)
  3CD8     L5G      9                        0.95                            1.11 (-0.16)
  3CTH     319      35                       1.54                            1.84 (-0.29)
  3I5N     B2D      17                       1.23                            1.69 (-0.46)
  3F66     IHX      900                      2.95                            2.88 (0.07)
  3L8V     L8V      8                        0.9                             0.72 (0.18)
  3QTI     3QT      14                       1.15                            1.18 (-0.04)
  3RHK     M97      520                      2.72                            2.60 (0.11)
  4DEG     0JJ      6                        0.78                            1.43 (-0.65)
  4DEH     0JK      612                      2.79                            2.71 (0.08)
  4EEV     L1X      42                       1.62                            1.09 (0.53)
  4GG7     0J8      6.5                      0.81                            0.72 (0.09)
                                             Average deviation               0.31

###### Experimentally observed and predicted IC50 values for 12 cyclin-dependent kinase-inhibitor complexes.

  PDB_ID                                                                                            LIG_ID   Experimental IC50 (nM)   Experimental log ( IC50 (nM))   Back-check Prediction
  ------------------------------------------------------------------------------------------------- -------- ------------------------ ------------------------------- -----------------------
  1AQ1                                                                                              STU      7                        0.85                            0.71 (0.13)
  1DI8                                                                                              DTQ      1000                     3                               3.07 (-0.07)
  1E1X                                                                                              NW1      2200                     3.34                            3.89 (-0.54)
  1H01                                                                                              FAL      22000                    4.34                            4.74 (-0.40)
  1W0X                                                                                              OLO      7                        0.85                            1.59 (-0.74)
  3S2P                                                                                              PMU      68                       1.83                            1.36 (0.48)
  3TIY                                                                                              TIY      17000                    4.23                            4.36 (-0.13)
  3TNW                                                                                              F18      20000                    4.3                             3.52 (0.78)
  3ULI                                                                                              1N3      70                       1.85                            1.48 (0.37)
  3UNJ                                                                                              0BX      11000                    4.04                            3.41 (0.63)
  3WBL                                                                                              PDY      23000                    4.36                            4.22 (0.14)
  4BGH                                                                                              3I6      4                        0.6                             1.24 (-0.63)
                                                                                                                                      Average deviation               0.49
                                                                                                                                                                      
  Note: The deviation between the predicted and experimental IC50 values is given in parenthesis.                                                                     

###### Experimentally observed and predicted IC50 values for 16 mitogen-activated protein kinase-inhibitor complexes

  PDB_ID                                                                                            LIG_ID   Experimental IC50 (nM)   Experimental log ( IC50 (nM))   Back-check Prediction
  ------------------------------------------------------------------------------------------------- -------- ------------------------ ------------------------------- -----------------------
  1W82                                                                                              L10      196                      2.29                            2.40 (-0.11)
  1WBN                                                                                              L09      350                      2.54                            2.20 ( 0.34)
  1ZYJ                                                                                              BI5      1500                     3.18                            2.84 ( 0.33)
  3FLZ                                                                                              FLZ      106                      2.03                            2.25 (-0.22)
  3FMH                                                                                              533      11                       1.04                            1.25 (-0.21)
  3HL7                                                                                              I47      110                      2.04                            1.56 ( 0.48)
  3HP2                                                                                              P36      680                      2.83                            3.07 (-0.24)
  3HRB                                                                                              I39      21                       1.32                            1.99 (-0.67)
  3IPH                                                                                              G11      316.23                   2.5                             2.40 ( 0.10)
  3L8X                                                                                              N4D      10                       1                               0.96 ( 0.04)
  3MVM                                                                                              39P      3.9                      0.59                            0.63 (-0.03)
  3NWW                                                                                              3NW      7                        0.85                            0.96 (-0.12)
  3S4Q                                                                                              NK0      4                        0.6                             0.44 ( 0.16)
  3UVP                                                                                              48       35                       1.54                            1.26 ( 0.28)
  3ZSG                                                                                              T75      7.1                      0.85                            1.15 (-0.30)
  4EWQ                                                                                              GG5      600                      2.78                            2.62 ( 0.16)
                                                                                                                                      Average deviation               0.29
                                                                                                                                                                      
  Note: The deviation between the predicted and experimental IC50 values is given in parenthesis.                                                                     

![(a) Scatter plot of experimental and back-check predicted IC50 values in 25 different kinase-inhibitor complexes, (b) Scatter plot of experimental and jack-knife predicted IC50 values in 25 different kinase-inhibitor complexes.](97320630012172F1){#F1}

![Scatter plot of experimental and predicted IC50 values in the test set of 93 kinase-inhibitor complexes.](97320630012172F2){#F2}

![Scatter plot of experimental and back-check predicted IC50 values in (a) 17 cyclic AMP-dependent kinase-inhibitor complexes; (b) 12 caesin kinase-inhibitor complexes; (c) 15 Hepatocyte growth factor receptor kinase-inhibitor complexes; (d)12 cyclin-dependent kinase-inhibitor complexes; (e) 16 mitogen-activated protein kinase-inhibitor complexes.](97320630012172F3){#F3}
